Teva Pharmaceuticals Donates to the National Multiple Sclerosis Society in recognition of Jack Osbou
Teva Pharmaceuticals Donates to the National Multiple Sclerosis Society in recognition of Jack Osbou/About-the-Society/News/Teva-Pharmaceuticals-Donates-to-the-National-Multi … read morePosted At: National MS Society
A decline in cognitive function should lead to a change in disease-modifying therapy – YesMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Genetic risk factors for pediatric-onset multiple sclerosisMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
In MS, can better sleep improve cognition?People with multiple sclerosis often have trouble with memory, attention and mental processing. New research shows some of these issues could stem from sleep disorders. … read morePosted...
Body size and physical exercise, and the risk of multiple sclerosisMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
- Next story National MS Society Studies Reveal Employment Concerns for People with MS—Webinars & Telelearnings E
- Previous story Epilepsy Pill May Protect Against MS-Related Nerve Damage: Phase 2 Trial Results Published
Join Our Mailing List
- MS: Gut bacteria may trigger harmful mechanismPosted At: Medical News Today
- World’s Largest MS Research Conference: Understanding MS and New Strategies to Restore Function
- Conceptual framework to study role of exercise in multiple sclerosis
- Insights into microbiome research 3: Who’s there versus what are they doing?
- Updates From ECTRIMS Research Conference
- Environmental factors may trigger onset of multiple sclerosis
- Genetic Ancestry Associated with Clinical Course in Hispanic-Latinos: Study is Ongoing
- Prognostic information for people with MS: Impossible or inevitable?
- New immunotherapy targeting blood-clotting protein
- Animal models of multiple sclerosis: From rodents to zebrafish